FDA Detects Unregistered Anti-diabetic Drug In Ghana
The Food and Drugs Authority (FDA) of Ghana has found an unregistered anti-diabetic medicine on the Ghanaian market and has thus warned Ghanaians about it.
The product named Galvus Met Tablet is manufactured by Novartis Pharmaceuticals in Turkey.
According to the Authority, the drug has found itself on the shelves of some pharmacies in the country and poses a great danger to consumers.
Its use has been associated with suspected therapeutic failure as well as poses life-threatening risks to consumers, the FDA said.
“The public is to note that the affected batches with only Turkish inscription have not been registered and therefore the quality, safety and efficacy cannot be ascertained.”
Measures
The FDA says it is taking steps to remove the drugs from the market while importers and retailers have been directed to halt their importation and supply across the country immediately.
“Importers and retailers of the pharmaceutical products are advised to immediately stop supplying all the listed batches and return any stock to the nearest FDA office for safe disposal.”
The Authority did not disclose any criminal prosecution against importers of the drug but indicated that it will not hesitate to prosecute such persons in the future.
Galvus Met Tablet is an anti-diabetic medicine that helps in lowering high blood sugar levels in patients suffering from Type 2 Diabetes.
